JPRN-UMIN000024500已完成未知
Evaluation of the immune-profiling for patients participating in Phase Ib/II Study of BBI608 in Combination with Pembrolizumab and the relationship between the immune-profiling and efficacy using paired biopsies and peripheral blood. - SCOOP BM study
ational Cancer Center Hospital East0 个研究点目标入组 59 人开始时间: 2016年10月20日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 发起方
- 入组人数
- 59
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1)Patients who are unfit for the study as determined by the attending physician
研究者
相似试验
已完成
不适用
Prospective study on evaluation of immunological response after SARS-CoV-2 vaccinatioCOVID-19JPRN-UMIN000045097Shionogi & Co., Ltd.205
招募中
不适用
Evaluation of immune function for patients with bile duct cancer before and after chemotherapyBile duct cancerJPRN-UMIN000009037Graduate School of Medicine, Yokohama City University30
招募中
Unknown
Evaluation of treatment response for immune checkpoint inhibitors in non-small cell lung cancer patients using [18F]F-AraG PET/CTlung cancerJPRN-jRCTs051220109akamoto Yuji60
已完成
不适用
Characterization of the immune response in patients with urothelial cell carcinoma of the bladder and during the BCG immunotherapy of bladder cancerC67Malignant neoplasm of bladderDRKS00003700Chirurgische Universitätsklinik, Abteilung für Urologie410
已完成
不适用
Evaluation of Immunological Changes in patients treated with CyberKnife® radiosurgery and RadiotherapyCTRI/2011/06/001800Health Care Global Enterprises Ltd100